Home   Business   Life Science

Subscribe Now

Life Science




Why investors cannot get enough of the Cambridge tech market

Why investors cannot get enough of the Cambridge tech market

Why investors cannot get enough of the Cambridge tech market

An interview with Stewart Frost, of J P Morgan Private Bank, on the outlook from investors.


Artios Pharma strikes stunning precision cancer drug deal worth up to $6.9bn with Merck KGaA

Artios Pharma strikes stunning precision cancer drug deal worth up to $6.9bn with Merck KGaA

Artios Pharma strikes stunning precision cancer drug deal worth up to $6.9bn with Merck KGaA

The companies aim to create a global powerhouse in DNA damage repair space.


OKRA Technologies unveils ValueScope to predict new drug prices years before launch

OKRA Technologies unveils ValueScope to predict new drug prices years before launch

OKRA Technologies unveils ValueScope to predict new drug prices years before launch

The AI-powereed system has been shown to be more than 90 per cent accurate.


Cerevance buoyed by postive clinical trial results for schizophrenia compound

Cerevance buoyed by postive clinical trial results for schizophrenia compound

Cerevance buoyed by postive clinical trial results for schizophrenia compound

The Cambridge Science Park company is using unique technology to target brain diseases.


Sareum welcomes revised deal between Sierra and CPF on checkpoint inhibitor

Sareum welcomes revised deal between Sierra and CPF on checkpoint inhibitor

Sareum welcomes revised deal between Sierra and CPF on checkpoint inhibitor

The agreement reduces potential milestone payments, but expedite its development.


Genome origami of Covid-19 virus unravelled by University of Cambridge researchers

Genome origami of Covid-19 virus unravelled by University of Cambridge researchers

Genome origami of Covid-19 virus unravelled by University of Cambridge researchers

Gurdon Institute work could prove key to developing new drugs against SARS-CoV-2.


AstraZeneca encouraged by rise in sales and profits despite pandemic disruption

AstraZeneca encouraged by rise in sales and profits despite pandemic disruption

AstraZeneca encouraged by rise in sales and profits despite pandemic disruption

The company has also announced a number of approvals.


Finalists in the 2020 Cambridge Independent Science and Technology Awards revealed

Finalists in the 2020 Cambridge Independent Science and Technology Awards revealed

Finalists in the 2020 Cambridge Independent Science and Technology Awards revealed

The shortlist of companies and individuals across 14 categories has been unveiled.


Congenica raises $50m to power global genomic medicine revolution

Congenica raises $50m to power global genomic medicine revolution

Congenica raises $50m to power global genomic medicine revolution

The funding will help it expand its product portfolio and reach more health systems.


Don’t miss our 9-page celebration of the finalists in the Cambridge Independent Science and Technology Awards 2020

Don’t miss our 9-page celebration of the finalists in the Cambridge Independent Science and Technology Awards 2020

Don’t miss our 9-page celebration of the finalists in the Cambridge Independent Science and Technology Awards 2020

From biotechs to AI companies, cleantechs to start-ups, an astonishing array of talent is on show.


Horizon Discovery snapped up by US-based PerkinElmer for $383m

Horizon Discovery snapped up by US-based PerkinElmer for $383m

Horizon Discovery snapped up by US-based PerkinElmer for $383m

The board of the Waterbeach-based cell engineering specialist say the company is ready for a US listing.


AstraZeneca’s open courtyard takes shape on Cambridge Biomedical Campus as trees planted

AstraZeneca’s open courtyard takes shape on Cambridge Biomedical Campus as trees planted

AstraZeneca’s open courtyard takes shape on Cambridge Biomedical Campus as trees planted

When the R&D Centre opens, the courtyard will be open to the public.


Kao Data discusses the growth of high performance computing in the life sciences

Kao Data discusses the growth of high performance computing in the life sciences

Kao Data discusses the growth of high performance computing in the life sciences

Director Adam Nethersole discusses how the pandemic has highlighted the importance of HPC for the sector.


bit.bio + London Institute for Mathematical Sciences = progress on industrial-scale production of all human cells

bit.bio + London Institute for Mathematical Sciences=progress on industrial-scale production of all human cells

bit.bio + London Institute for Mathematical Sciences = progress on industrial-scale production of all human cells

The new partnership will enable new cell therapies and even accelerate prototype organ printing.


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More